Dental Literature Watch · Guideline · Radiology
ADA/AAOMR Radiograph and CBCT Selection — the 2012 Guidance Is Replaced
TL;DR
- This replaces the 2012 ADA/FDA "Dental Radiographic Examinations" document that most practices still work from.
- A thorough evaluation of history and clinical findings must precede radiographic examination. Imaging follows the exam; it does not substitute for it.
- Previously obtained images should be reviewed before new ones are taken.
- All modalities, and CBCT especially, should be used judiciously to minimise cumulative radiation exposure.
- Imaging decisions rest on medical and dental history, clinical findings, disease risk assessment, and specific clinical conditions — not on a calendar.
- These are consensus recommendations, not formal guidelines, because the evidence was too limited to support the stronger designation. The panel says so explicitly.
How it was built
| Who | ADA Council on Scientific Affairs with the American Academy of Oral and Maxillofacial Radiology — a 6-member expert panel plus an 18-member consultant group |
| Method | Systematic review of existing systematic reviews and organisational guidelines across 9 clinical questions, then a structured non-Delphi consensus |
| Output | Consensus recommendations — the evidence base did not support formal guidelines |
| Scope | General and paediatric dental practitioners, across imaging modalities including CBCT |
💎 Insight — what this means chairside
The target is the automatic bitewing
"Everyone gets bitewings at recall" is a scheduling rule, not a clinical decision.
This document puts risk assessment ahead of interval: the low-risk adult with no clinical findings and no new symptoms does not need films on a timer.
"Everyone gets bitewings at recall" is a scheduling rule, not a clinical decision.
This document puts risk assessment ahead of interval: the low-risk adult with no clinical findings and no new symptoms does not need films on a timer.
Review the old films first — this is a real recommendation, not a courtesy
Records requested from a previous office and never actually opened are how patients accumulate duplicate exposure.
It is also the cheapest possible way to avoid retaking something you already have.
Records requested from a previous office and never actually opened are how patients accumulate duplicate exposure.
It is also the cheapest possible way to avoid retaking something you already have.
CBCT is singled out by name
CBCT delivers far more dose than intraoral films, and its availability in general practice has run ahead of the guidance on when to use it.
"Judiciously" here means a specific clinical question that a lower-dose image cannot answer — not a routine adjunct to every implant or endodontic workup.
CBCT delivers far more dose than intraoral films, and its availability in general practice has run ahead of the guidance on when to use it.
"Judiciously" here means a specific clinical question that a lower-dose image cannot answer — not a routine adjunct to every implant or endodontic workup.
Consensus, not guideline, is an honest label
The panel could have dressed this up. Saying the evidence only supports consensus tells you how much weight to put on any single line.
It is also why the document reads as a decision framework rather than a schedule.
The panel could have dressed this up. Saying the evidence only supports consensus tells you how much weight to put on any single line.
It is also why the document reads as a decision framework rather than a schedule.
⚠️ The catch
It gives you a framework, not a table you can pin to the wall
The 2012 document's appeal was its grid of intervals by age and risk.
Replacing that with "assess risk and decide" is more defensible and much harder to operationalise across a team of hygienists and associates.
The 2012 document's appeal was its grid of intervals by age and risk.
Replacing that with "assess risk and decide" is more defensible and much harder to operationalise across a team of hygienists and associates.
Insurance and record-keeping have not caught up
Payers and practice-management software still assume interval-based radiographs.
Documenting the risk assessment that justified not imaging matters as much as documenting the image itself.
Payers and practice-management software still assume interval-based radiographs.
Documenting the risk assessment that justified not imaging matters as much as documenting the image itself.
⚡ Bottom line
- Recall patient, low caries risk, no symptoms, no clinical findings → no automatic films. Assess, then decide.
- New patient with records from a previous office → review those images before ordering your own.
- Considering CBCT → name the specific question it will answer that a lower-dose image cannot.
- High caries risk, active disease, or a specific clinical finding → that is what justifies imaging, and the interval follows the risk.
- Still working from the 2012 ADA/FDA chart → it has been replaced.
🧪 Questions
Tap an answer — instant grade, deciding line, and the trap.
A 41-year-old patient attends for a routine recall. She has no symptoms, no new restorations in eight years, excellent oral hygiene, no active caries at her last three visits, and a clinical examination today is unremarkable. Her last bitewings were taken 18 months ago at your practice. Your software flags her as due for bitewings. What does the 2026 ADA/AAOMR guidance support?
Deciding line: the recommendations put history, clinical findings, and disease risk assessment ahead of any fixed interval, and this patient has low risk with an unremarkable examination. Trap: the interval-based answer is the engineered trap because it is how most practice software and the superseded 2012 chart both work; the panoramic option is wrong on its premise, since a panoramic is not a substitute for caries detection and does not reliably lower the relevant dose.
A 55-year-old man is being assessed for a single implant to replace a lower first molar. He has no relevant medical history. You have a recent periapical and a panoramic radiograph. A colleague suggests a CBCT is standard of care before any implant. What does the 2026 guidance support?
Deciding line: the recommendations single out CBCT for judicious use, tying it to a specific clinical question and to minimising cumulative exposure rather than to a procedure type. Trap: treating CBCT as routine before every implant is the most common real-world practice and the engineered trap here; avoiding CBCT entirely overcorrects, since proximity to the inferior alveolar canal is exactly the question CBCT answers well.